BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2019 3:03:24 AM | Browse: 917 | Download: 1555
 |
Received |
|
2019-02-25 03:12 |
 |
Peer-Review Started |
|
2019-02-27 11:20 |
 |
To Make the First Decision |
|
2019-04-12 00:29 |
 |
Return for Revision |
|
2019-04-19 09:54 |
 |
Revised |
|
2019-07-26 07:08 |
 |
Second Decision |
|
2019-08-07 00:45 |
 |
Accepted by Journal Editor-in-Chief |
|
2019-08-07 22:58 |
 |
Accepted by Executive Editor-in-Chief |
|
2019-08-21 04:14 |
 |
Articles in Press |
|
2019-08-21 04:14 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2019-09-17 12:04 |
 |
Publish the Manuscript Online |
|
2019-09-25 03:03 |
ISSN |
1948-0210 (online) |
Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Neurosciences |
Manuscript Type |
Review |
Article Title |
Using induced pluripotent stem cells for modeling Parkinson’s disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Min-Jing Ke, Cheong-Meng Chong and Huan-Xing Su |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Huan-Xing Su, MD, PhD, Associate Professor, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, University Northern Road, Macao 999078, China. huanxingsu@umac.mo |
Key Words |
Parkinson's disease; Dopaminergic neurons; Induced pluripotent stem cells; Somatic cell reprogramming; Aging; |
Core Tip |
Human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons hold great promise for studying disease mechanisms underlying Parkinson’s disease (PD) and testing drug effects. A number of reviews have previously summarized the potential use of patient iPSCs for modeling PD. However, few of them comprehensively discuss the establishment of gene-editing-based iPSCs for PD and their application in research. Our objective is to consolidate the current literature on various iPSC-based PD models either derived from PD patients through reprogramming technology or established by gene-editing technology, and provide new insights into the application of iPSC PD models. |
Publish Date |
2019-09-25 03:03 |
Citation |
Ke MJ, Chong CM, Su HX. Using induced pluripotent stem cells for modeling Parkinson’s disease. World J Stem Cells 2019; 11(9):634-649 |
URL |
https://www.wjgnet.com/1948-0210/full/v11/i9/634.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v11.i9.634 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345